Methylene blue attenuates mitochondrial dysfunction of rat kidney during experimental acute pancreatitis

Irma Kuliaviene1, Rasa Baniene2, Simona Virketyte2

  • 1Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Abstract

Insights

Methylene blue (MB) improved kidney mitochondrial function in rats with acute pancreatitis (AP), but did not protect the pancreas. This suggests MB may help mitigate kidney damage associated with AP.

Area of Science:

  • Biochemistry
  • Pathophysiology
  • Pharmacology

Background:

  • Mitochondrial dysfunction is implicated in acute pancreatitis (AP) pathogenesis and subsequent kidney failure.
  • Investigating therapeutic agents that target mitochondrial function is crucial for managing AP complications.

Purpose of the Study:

  • To evaluate the impact of methylene blue (MB) on pancreatic and kidney mitochondrial respiration in a rat model of AP.
  • To determine if MB can ameliorate mitochondrial dysfunction in organs affected by AP.

Main Methods:

  • Acute pancreatitis was induced in male Wistar rats using sodium taurocholate.
  • Rats received intravenous methylene blue (MB) or saline prior to AP induction.
  • Pancreas and kidney tissues were analyzed for mitochondrial respiratory function using oxygraphic and spectrophotometric assays.

Main Results:

  • Methylene blue (MB) did not prevent AP-induced pancreatic mitochondrial respiration inhibition.
  • MB significantly enhanced kidney mitochondrial respiration, particularly with complex I-dependent substrates (glutamate and malate).
  • MB increased complex I activity in AP-damaged kidney mitochondria but did not affect respiration with succinate.

Conclusions:

  • Methylene blue (MB) administration can ameliorate disturbances in kidney mitochondrial energy metabolism during experimental acute pancreatitis.
  • MB shows potential as a therapeutic agent for kidney complications associated with severe AP.

Related Concept Videos